Purchase Order 75N92025P00375
Award Date 9/12/25
Potential Completion Date 9/11/26
Potential Value $53K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $177,991.20 firm fixed price purchase order to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic profiling of individuals of African descent. The order was issued directly under a solicitation, without the use of a set-aside. Metabolon provides metabolomics services and solutions to government agencies, leveraging its proprietary technology...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $118,993 firm fixed price purchase order to Metabolon, Inc. to conduct research analyzing the metabolomic profile associated with cardiometabolic traits in African Americans. The contract has a period of performance from August 29, 2023 through August 28, 2024. Under the solicitation seeking this analysis, Metabolon will leverage its expertise in metabolomics to provide...
- This is a firm fixed price purchase order contract awarded to Metabolon, Inc., a small disadvantaged business, by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The $279,378 contract is to provide metabolomics services to support the GENEFORECAST, SIT, and MHGRID research projects. Metabolon is an experienced provider of specialized metabolomics analysis capabilities for the federal government, having supported numerous...
- Metabolite Laboratories, Inc. was awarded a $5,000 purchase order contract by the National Institutes of Health's National Human Genome Research Institute to provide unspecified products or services in support of genomic research efforts. With a period of performance of August 14, 2015 through August 13, 2016 and firm fixed pricing, this contract leveraged the NIH's Scientific Management Review Board vehicle to procure needed capabilities for the agency's human genome initiatives. No...
- The NIH Clinical Center awarded a $24,784 firm fixed-price purchase order to Metabolon, Inc. for metabolomics analysis services. The contract, which commenced on September 9, 2025, with an ultimate completion date of September 8, 2026, represents a task order under Metabolon's existing Indefinite Delivery Contract with the NIH Clinical Center valued at $250,000. No set-aside designation was utilized for this award. Metabolon, a self-certified small disadvantaged business headquartered in...
- This is a firm-fixed price purchase order awarded by the National Institutes of Health's National Human Genome Research Institute to Metabolon, Inc., a small disadvantaged business, for the purpose of discovering diabetes metabolomics biomarkers in plasma and tissue samples from the NHGRI Fusion cohort clinical study, including meta-analysis with the METSIM cohort. The potential value of the contract is USD 376,105.00, with a completion date of May 29, 2019. Metabolon is a provider of...
- The National Human Genome Research Institute (NHGRI), a civilian federal agency, awarded a $24,981.00 firm fixed-price purchase order contract to Metabolic Solutions, LLC, doing business as Metabolic Solutions Inc. The contract is for CO2 measurements and is set to run until March 11, 2026. Metabolic Solutions is a for-profit limited liability company that specializes in advanced analytical services, with expertise in stable isotope analysis and chemical testing. The company has a track record...
- The National Institutes of Health National Human Genome Research Institute awarded Metabolon, Inc. a $53,420 fixed-price purchase order to conduct fecal metabolomic profiling of individuals of African descent with metabolic disorders. The work will be performed in Morrisville, North Carolina over a one-year period ending August 2024. Through this contract, Metabolon will analyze stool samples to develop metabolic profiles for research participants, as requested in the original solicitation...
- Metabolon, Inc., a small disadvantaged business, was awarded a $244,993.28 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute. The purpose is to perform metabolomic profiling of individuals of African descent with metabolic disorders, including a focus on comparing the metabolic profiles of those with high versus low triglyceride levels. This award is part of the Africa America Diabetes study and aims to integrate multiple omics...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences awarded a $195,000.00 firm fixed price purchase order to Metabolon, Inc., a self-certified small disadvantaged business, for the analysis of the metabolome of human pluripotent stem cells and their differentiated progeny. The contract does not have a set-aside designation. Metabolon provides metabolomics services and solutions to federal agencies like the...